Skip to main content

Table 5 Secondary metabolites identified from the secretome of strain MHSD-37 before and after exposure to Pb using LC-MS.

From: In silico biotechnological potential of Bacillus sp. strain MHSD_37 bacterial endophyte

 

Precursor (m/z)

RT

Nature of compound

Molecular formula

Compound

Biological activity

Control

488.24

6.08

N-acyl amines

C20H33N5O9

Goralatide

Anticancer

365.28

14.99

Alpha amino acids

C19H39N2O3

Empigen BR

Surfactant

279.16

16.19

Benzoic acid esters

C16H22O4

Hatcol DBP

Plasticiser

362.21

19.11

Cinnamic acid esters

C24H27NO2

Octocrylene

Sunscreen

482.41

19.77

Fatty Acyls

C25H52O7

Tridecylhexaethoxylate

Surfactant

311.17

19.82

Retro-dihydrochalcones

C20H22O3

Avobenzona

Sunscreen

427.38

23.65

Fatty alcohol esters

C26H50O4

Witamol 500

Plasticiser

631.41

24.44

Terpene glycosides

C33H58O11

Kurilensoside f

Antimicrobial

506.53

24.48

N-acyl amines

C34H67NO

Oleyl palmitamide

Plasticiser

551.59

24.48

N-acyl amines

C36H74N2O

Butanamide, 4-(dioctylamino)

Anticancer

547.4

25.53

Benzoic acid esters

C33H54O6

hatcol 2000

Plasticiser

Pb treated

734.31

6.13

Diterpenoids

C40H47NO12

3’-N-Debenzoyl-2’-deoxytaxol

Anticancer

545.26

6.4

Oligopeptide

C22H36N6O10

Acetyl-DTTPA-NH2

Anti-HIV

261.12

6.73

Alpha amino acid

C14H16N2O3

Maculosin

Antioxidant

314.17

7

Lipid

C15H22O3

Racemosalactone A

Anticancer

197.13

7.01

Alpha amino acid

C10H16N2O2

Cyclo(-Pro-Val)

Antifungal

528.27

7.31

Oligopeptide

C23H37N5O9

n.a.

Antimalarial

262.14

7.39

Peptide

C14H18N2O3

Phenylalanylproline

Antimcrobial

530.25

7.61

Oligopeptide

C22H35N5O10

n.a.

Anticancer

765.34

7.66

Oligopeptide

C38H48N6O11

n.a.

Antimalarial

408.23

7.69

Oligopeptide

C19H29N5O5

n.a.

Anti-angiotensi II

680.37

7.69

Oligopeptide

C31H49N7O10

n.a.

Anticancer

702.35

7.69

Oligopeptide

C36H49N5O8

n.a.

Anti-virus

401.21

7.76

Oligopeptide

C17H28N4O7

n.a.

Antibacterial

444.23

7.77

Oligopeptide

C16H29N9O6

n.a.

Anticlots

888.42

7.79

Oligopeptide

C39H59N11O14

n.a.

Anti-virus

302.15

7.94

Oligopeptide

C16H19N3O3

D-Proline, D-tryptophyl

Antimicrobial/anticancer

495.21

8.01

Oligopeptide

C21H28N8O5

n.a.

Antimicrobial/anticancer

587.31

8.25

Oligopeptide

C25H42N6O10

n.a.

Antimicrobial

757.32

8.29

Oligopeptide

C39H44N6O10

n.a.

Anticancer

411.26

8.32

Oligopeptide

C20H34N4O5

n.a.

Antimicrobial

211.14

8.37

Alpha amino acid

C11H18N2O2

Gancidin W

Antimalarial agent

578.29

8.39

Oligopeptide

C27H39N5O9

n.a.

Antimalarial agent

484.25

8.46

alpha amino acid

C26H33N3O6

Carbobenzoxy-Ala-Ile-Phe-COOH

Anti-HIV

574.32

9.17

Oligopeptide

C29H43N5O7

n.a.

Anti-virus

701.32

9.29

Phenylalanine

C38H44N4O9

n.a.

Anti-virus

481.21

9.48

Oligopeptide

C25H28N4O6

n.a.

Anticancer

883.27

9.88

Cyclic depsipeptides

C39H42N6O18

Corneybactin

Iron acquistion

365.28

14.78

Alpha amino acids

C19H39N2O3

Empigen BR

Surfactant

279.16

16.51

Benzoic acid esters

C16H22O4

Hatcol DBP

Plasticiser

362.21

19.11

Cinnamic acid esters

C24H27NO2

Octocrylene

Sunscreen

311.17

19.82

Retro-dihydrochalcones

C20H22O3

Avobenzona

Sunscreen

631.41

24.44

Terpene glycosides

C33H58O11

Kurilensoside f

Antimicrobial

506.53

24.48

N-acyl amines

C34H67NO

Oleyl palmitamide

Plasticiser

551.59

24.48

N-acyl amines

C36H74N2O

Butanamide, 4-(dioctylamino)

Anticancer

547.4

25.53

Benzoic acid esters

C33H54O6

hatcol 2000

Plasticiser

  1. n.a. = no similar annotated compounds in the databases